Before you decide you have "done enough" for the SCE in Neurology, you need evidence you have actually covered the blueprint — not a bank that reads as 100% complete. This is the exam-level hub for that single decision. It gives you a checklist, a coverage table and a stop/continue tree, so the question "am I ready to stop doing new questions?" is answered by measured gaps against the official Federation blueprint, not by how much of one product you have clicked through.
The direct answer: the minimum evidence to claim coverage
You can say you have covered SCE Neurology when, and only when, you can show all of the following — as a checklist, not a timetable:
- Every blueprint domain has a recorded first-attempt accuracy on unseen, timed items, not just "questions seen".
- No domain sits below your personal threshold (say 70% first-attempt) without a dated plan to fix it.
- You have interpreted neuroimaging, EEG/EMG and clinical data items under time, not just read about them.
- Your high-confidence errors are trending down — the dangerous "sure and wrong" bucket.
- You have sat at least one full-length, timed, mixed block across both papers' worth of material and calibrated against official sample questions.
- Guidance-sensitive topics carry a source and date you have checked.
If any line is unproven, you have not covered the blueprint — you have finished a product. Those are different claims.
Current exam snapshot
The SCE in Neurology is set by the Federation of Royal Colleges of Physicians (verified 21 July 2026). The format is two papers of 100 best-of-five (BOF) questions each — 200 questions in total — with each paper lasting 3 hours, sat in one day, computer-based via Surpass at a test centre, one mark per correct answer and no negative marking. There are no formal entry requirements, though UK trainees normally sit it in the penultimate year of higher specialty training; success confers the post-nominal SCE (Neurology). It is a written knowledge exam — there is no OSCE or viva — so everything is assessed as best-of-five items, including image and data interpretation.
The authoritative content map is the Federation's SCE Neurology blueprint, which distributes the 200 questions across thirteen domains. Because it is published and weighted, it is the only defensible basis for a coverage claim.
Build a blueprint coverage table
Rebuild this table with your own numbers. The official weights below are from the Federation blueprint (verified 21 July 2026); the remaining columns are yours to fill from your bank's analytics.
| Blueprint domain | Official weight (of 200) | Questions attempted | First-attempt accuracy | Last reviewed | Confidence |
|---|---|---|---|---|---|
| Disorders of consciousness and epilepsy | 20 | ||||
| Neurogenetics/endocrinology/toxicology/urology/otology | 20 | ||||
| Neuro-inflammatory disorders | 20 | ||||
| Cerebrovascular disease | 15 | ||||
| Peripheral nervous system and muscle | 15 | ||||
| Special groups (elderly, children, pregnancy, end of life) | 15 | ||||
| Neurophysiology, neuroradiology, neuropathology | 15 | ||||
| Neurorehabilitation, neuropsychology, neuropsychiatry | 15 | ||||
| Neurosurgery and intensive care | 15 | ||||
| Pain and headache | 15 | ||||
| Parkinsonism and movement disorders | 15 | ||||
| Cranial nerves and visual system | 10 | ||||
| Spinal cord and motor neurone disease | 10 |
A domain is "covered" only when its accuracy is at threshold and recently reviewed. A high attempt count with stale or low accuracy is a red flag, not reassurance.
Ten domain-level blind spots most likely to hide
Self-selected practice systematically leaves the same corners dark. Before you stop, have a neurology-aware reviewer confirm you have genuinely tested these:
- Neurogenetics — trinucleotide-repeat and channelopathy detail that is easy to skim.
- Neuro-otology — vertigo discrimination, nystagmus patterns, the HINTS logic.
- Neuro-ophthalmology — pupillary and visual-field localisation.
- Neuromuscular junction and myopathy — beyond myasthenia to the rarer myopathies.
- Autonomic and neuro-urology — often absent from commercial banks.
- Neurology in pregnancy and end of life — the "special groups" domain.
- Neuropsychiatry and functional disorders — frequently under-tested.
- CNS infection and neuro-inflammation overlap — autoimmune encephalitis, the newer antibody syndromes.
- Neurophysiology interpretation — EEG and nerve-conduction patterns as data items.
- Therapeutics detail — anti-seizure and immunotherapy specifics, verified against the SmPC/eMC and NICE/CKS rather than habit.
Requiring exam-specific clinician review before you declare coverage is not a formality; these are precisely the domains a candidate cannot audit alone because they do not know what they have not seen.
Format checklist: the reasoning the SCE actually tests
Because everything is written BOF, "format" here means the reasoning types the paper demands. Verify deliberate practice on each:
- Localisation: given signs, place the lesion — the core neurological skill, and one that pattern-matching a bank can fake. Test it on unfamiliar stems.
- Neuroimaging: MRI/CT stills as items — can you read them, not just recognise the caption?
- EEG/EMG and neurophysiology: trace and study interpretation under time.
- Syndrome discrimination: telling near-neighbours apart (e.g., the parkinsonian syndromes, the inflammatory neuropathies) rather than naming the obvious case.
If your practice has trained recognition of classic presentations but not discrimination between look-alikes, you have a format gap even at 90% overall.
Interpretation checklist
Log deliberate, timed practice on each data type the neurology blueprint can present: neuroimaging (MRI, CT, angiography stills), neurophysiology (EEG, nerve conduction, EMG), laboratory and CSF trends, genetics results, and the ethics that recur in neurology — capacity, end-of-life and consent in progressive disease. Basic statistics and evidence appraisal appear where trials underpin management. Tick each only when you have interpreted it unseen and at pace.
Recency checklist
Neurology management moves. Flag the guidance-sensitive topics — acute stroke and thrombectomy windows, status epilepticus protocols, MS disease-modifying therapy, myasthenia and immunotherapy, migraine prevention including newer agents, Parkinson's management — and record for each the source and date and jurisdiction you checked (UK NICE/CKS, specialist society guidance, the SmPC/eMC for drug specifics). An item you learned two revision cycles ago may now be wrong; a dated source is your protection.
Performance checklist
Coverage is also about conditions, not just content. Confirm: you have done unseen, timed, mixed blocks (not topic-by-topic in an untimed comfort zone); your speed matches ~1.8 minutes per item; your high-confidence errors are falling; your retention holds when a topic is re-tested after a gap; and you have calibrated against the Federation's official sample questions, which are the closest thing to the real cognitive level. Any of these unmet is a reason to keep going.
Three coverage-reading mistakes this checklist is designed to stop
First, reading the headline percentage as coverage. An 84% overall can hide three sub-threshold domains and a stale one; the blueprint table exists precisely to break the average back into its parts. Second, counting attempts as mastery. "I've done 1,400 questions" describes effort, not competence — a domain with 200 attempts at 60% accuracy is a weakness wearing the costume of thoroughness, and only first-attempt accuracy on unseen items counts. Third, auditing yourself in domains you cannot see into. The blind-spot list exists because a candidate genuinely does not know what neuro-otology or neurogenetics content they have never met; self-assessment silently skips it. That is why the checklist requires an exam-aware reviewer before you declare coverage — not as ceremony, but because the domains most likely to lose you marks are the ones you are least equipped to notice alone. Catching these three converts a comfortable feeling of "nearly done" into an evidenced claim you can stand behind.
Stop/continue decision tree
Use the measured gap, not novelty or fatigue, to choose the next action:
- Continue new questions if any blueprint domain is still below threshold or unattempted, or your unseen accuracy is still rising.
- Consolidate (stop new items, review and re-test misses) if breadth is complete but retention wobbles or high-confidence errors persist.
- Simulate (full-length timed mixed mock) if accuracy and breadth are solid but you have not proven stamina and pace across a paper.
- Seek teaching if a specific domain resists self-study after honest testing — get a neurologist to walk the reasoning.
- Rest if scores are plateauing from fatigue rather than gaps; a recovered brain outperforms a ground-down one.
Downloadable one-page checklist (copy this)
- Every blueprint domain has a recorded unseen, timed first-attempt accuracy
- No domain below threshold without a dated fix plan
- Localisation and syndrome discrimination tested on unseen stems
- Neuroimaging + EEG/EMG interpreted under time
- Guidance-sensitive topics carry source + date + jurisdiction
- High-confidence errors trending down
- At least one full-length, timed, mixed mock completed
- Calibrated against the Federation official sample questions
- Neurology-aware reviewer has checked the ten blind spots
Worked example (invented data)
A trainee's table shows 190/200-equivalent domains at or above 72% — except neuro-otology (58%, attempted 9), neurogenetics (61%, attempted 12) and neurophysiology interpretation (64%, last reviewed 5 weeks ago). Overall bank percentage: 84%. The naive read is "84%, nearly done". The checklist read is different: three named domains are below threshold, one is stale, and no full-length mixed mock has been sat. The decision is not "stop" but continue on three domains, then simulate — a targeted week, not another full pass. The overall percentage was hiding the exact gaps that lose marks.
From this checklist to your bank choice
This hub is deliberately platform-neutral: it defines what "covered" means, not which product to buy. Once you have your coverage table, the choice of bank follows from the gaps rather than from marketing. If whole domains are unattempted, you need breadth — a purpose-built specialty bank that spans the thirteen domains, and the NeuroSCE question-style audit and the Licence Medical coverage audit walk through what each covers against this same blueprint. If instead your scores are inflating because you recognise a bank's items, the gap is not coverage but calibration, and the fix is an unseen measurement source rather than a second content bank. Match the tool to the measured deficiency: breadth for empty domains, unseen volume for contaminated scores, teaching for a domain that resists self-study. The checklist keeps that decision honest by forcing it back onto the table.
Frequently asked questions
How do I know whether I have covered the full SCE Neurology blueprint? You have covered it when every one of the thirteen Federation blueprint domains carries a recorded, at-threshold, recently reviewed first-attempt accuracy on unseen timed items — and a neurology-aware reviewer has confirmed the easily hidden domains (neurogenetics, neuro-otology, autonomic/urology, neurophysiology interpretation) are genuinely tested. A bank reading 100% "complete" proves you have seen its items, not that you have covered the blueprint; only a domain-by-domain coverage table against the official weighting can support that claim.
Can one question bank be enough for SCE Neurology? Sometimes for breadth, rarely for calibration. A single strong specialty bank can span the blueprint, but every bank has a house style and blind spots, and once you have seen its items your scores drift from recognition rather than reasoning. A measured approach is to run a primary bank for volume and a second, unseen source purely to measure — the two-Q-bank logic — so your readiness signal stays honest. Whether you need a second bank is itself a measured decision: add one only if your primary leaves domains untested or your accuracy is inflating on familiar items.
What should I measure instead of my overall Q-bank percentage for SCE Neurology? Measure first-attempt accuracy per blueprint domain on unseen, timed items; the size and trend of your high-confidence error bucket; retention when topics are re-tested after a gap; your pace against ~1.8 minutes per item; and your calibration against the official sample. The overall percentage blends easy and hard, seen and unseen, into one flattering number — as the standing caveat puts it, your Q-bank percentage is not your exam score. Domain-level unseen accuracy is the metric that predicts the real thing.
When should I stop doing new SCE Neurology questions? Stop starting new items when every blueprint domain is at threshold on unseen practice, your high-confidence errors are low and stable, and you have proven pace and stamina in a full-length timed mock — then switch from acquisition to consolidation and simulation. Stopping earlier because a bank is "finished" or a percentage looks high is the classic error; stopping because the measured gaps are closed is the correct one. If any domain is still weak, "new questions" is exactly what you still need.
Which SCE Neurology resource should I use for my weakest component? Match the resource to the failure mode. If the weakness is knowledge, go to a source-led revision resource and the primary literature or society guidance for that domain; if it is discrimination between look-alike syndromes, you need volume and variety of unseen items, not more reading; if it is image or neurophysiology interpretation, use a resource rich in stills and traces; if it is pace, you need timed mixed blocks. iatroX is well suited to the measurement job — confirming on fresh, unseen items whether the weak component has actually improved — while a specialty bank or teaching supplies the domain depth.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 21 July 2026. Exam structure and blueprint weightings are taken from the Federation of Royal Colleges of Physicians; verify current paper and question counts and the latest blueprint version on thefederation.uk, as these are periodically revised. Vendor figures for any commercial bank are vendor-reported and change. Disclosure: iatroX operates a UK question bank and is not a neurology-specific SCE bank; its role here is the cross-specialty knowledge and unseen-measurement layer that sits alongside a specialty SCE bank, and this hub is deliberately vendor-neutral. Corrections are welcome via the feedback route on iatrox.com.
References: Federation of Royal Colleges of Physicians — SCE in Neurology exam page, blueprint and sample questions (thefederation.uk). iatroX internal: Your Q-Bank Percentage Is Not Your Exam Score; question-bank completion is not coverage; the two-Q-bank rule; platform audits: what Licence Medical tests for SCE Neurology and NeuroSCE question style.